P. Schnitzler et al., Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture, PHARMAZIE, 56(4), 2001, pp. 343-347
The antiviral effect of Australian tea tree oil (TTO) and eucalyptus oil (E
UO) against herpes simplex virus was examined. Cytotoxicity of TTO and EUO
was evaluated in a standard neutral red dye uptake assay. Toxicity of TTO a
nd EUO was moderate for RC-37 cells and approached 50% (TC50) at concentrat
ions of 0.006% and 0.03%, respectively, Antiviral activity of TTO and EUO a
gainst herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2
(HSV-2) was tested in vitro on RC-37 cells using a plaque reduction assay.
The 50% inhibitory concentration (IC50) of TTO for herpes simplex virus pla
que formation was 0.0009% and 0.0008% and the IC50 of EUO was determined at
0.009% and 0.008% for HSV-1 and HSV-2, respectively. Australian tea tree o
il exhibited high levels of virucidal activity against HSV-1 and HSV-2 in v
iral suspension tests. At noncytotoxic concentrations of TTO plaque formati
on was reduced by 98.2% and 93.0% for HSV-1 and HSV-2, respectively. Noncyt
otoxic concentrations of EUO reduced virus titers by 57.9% for HSV-1 and 75
.4% for HSV-2. Virus titers were reduced significantly with TTO, whereas EU
O exhibited distinct but less antiviral activity. In order to determine the
mode of antiviral action of both essential oils, either cells were pretrea
ted before viral infection or viruses were incubated with TTO or EUO before
infection, during adsorption or after penetration into the host cells. Pla
que formation was clearly reduced, when herpes simplex virus was pretreated
with the essential oils prior to adsorption. These results indicate that T
TO and EUO affect the virus before or during adsorption, hut not after pene
tration into the host cell. Thus TTO and EUO are capable to exert a direct
antiviral effect on HSV. Although the active anti herpes components of Aust
ralian tea tree and eucalyptus oil are not yet known. their possible applic
ation as antiviral agents in recurrent herpes infection is promising.